EAMAX | VEMRX | EAMAX / VEMRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 3 years | 14 years | - |
Gain YTD | 12.754 | 11.041 | 116% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1500 | 100000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.55M | 111B | 0% |
Annual Yield % from dividends | 1.35 | 3.48 | 39% |
Returns for 1 year | 14.87 | 13.00 | 114% |
Returns for 3 years | N/A | -0.71 | - |
Returns for 5 years | N/A | 11.99 | - |
Returns for 10 years | N/A | 34.70 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PHLAX | 40.39 | N/A | N/A |
PGIM Jennison Health Sciences A | |||
NQCCX | 3.67 | -0.02 | -0.54% |
Nuveen Large Cap Value Opportunities C | |||
GLVAX | 81.00 | -0.59 | -0.72% |
Invesco Global Focus A | |||
VSFSX | 25.60 | -0.36 | -1.39% |
Federated Hermes Clover Small Value R6 | |||
PRGSX | 65.19 | -4.40 | -6.33% |
T. Rowe Price Global Stock |